| Date | Time | Source | Headline | Symbol | Company |
| 09/24/2008 | 8:00PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Initial Statement of Beneficial Ownership (3) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 09/22/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 09/22/2008 | 8:00AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. to Present at UBS Global Life Sciences Conference | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 08/27/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. To Present at NewsMakers in the Biotech Industry Conference | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 08/14/2008 | 2:42PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Quarterly Report (10-Q) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 08/13/2008 | 9:15AM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 08/13/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 08/12/2008 | 4:44PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 07/30/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. To Announce Second Quarter Financial Results on August 13, 2008 | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/20/2008 | 2:52PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/20/2008 | 2:46PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/20/2008 | 2:40PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/20/2008 | 2:33PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/20/2008 | 2:28PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/19/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. To Present At Jefferies Healthcare Conference | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/18/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Presents Three Studies on Trofex(TM) Program for Prostate Cancer Diagnosis and Staging | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/18/2008 | 8:15AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Reports Onalta(TM) Tissue Distribution Data Support Clinical Development Program | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/17/2008 | 4:54PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Prospectus filed pursuant to Rule 424(b)(3) (424B3) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/17/2008 | 6:01AM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Notice of Effectiveness (EFFECT) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/16/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Reports Preclinical Data on Solazed(TM) for Treatment of Metastatic Melanoma at Society | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/16/2008 | 8:15AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Announces Additional Panel Participation at the BIO 2008 International Convention | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/12/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Initiates Trofex(TM) Phase 1 Trial for the Detection and Staging of Metastatic Prostate | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/11/2008 | 8:30AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Announces Panel Participation at the BIO 2008 International Convention | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 06/02/2008 | 8:15AM | Business Wire | Molecular Insight Pharmaceuticals, Inc. Reports Preliminary Results of Azedra(TM) Phase I Trial in Neuroendocrine Cancer Patient | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 05/22/2008 | 4:59PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 05/22/2008 | 4:57PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 05/22/2008 | 4:55PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 05/22/2008 | 4:49PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 05/22/2008 | 4:38PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |
| 05/21/2008 | 4:39PM | Edgar (US Regulatory) | Molecular Insight Pharmaceuticals, Inc. - Current report filing (8-K) | NASDAQ:MIPI | Molecular Insight Pharmaceuticals (MM) |